Pharmaceuticals, Biotechnology and Life Sciences
BASEL, Switzerland, Oct. 24, 2022 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV) (“Myovant”) today announced the cancellation of its earnings…
SOUTH SAN FRANCISCO, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading human genetics…
IRVINE, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), today announced that the Company will…
– Results identify mood, sleep and pain disorders as the most common comorbidities in people living with narcolepsy – –…
SAN DIEGO, Oct. 24, 2022 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical…
WALTHAM, Mass., Oct. 24, 2022 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), a clinical-stage biopharmaceutical company on a mission to…
SAN CARLOS, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel…
SAN CARLOS, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity…
BEAVERTON, Ore., Oct. 24, 2022 (GLOBE NEWSWIRE) — Trusting Heart Blood Center (THBC) held a ribbon cutting ceremony on October…
RetinalGeniX Technologies Invites Individual and Institutional Investors, Advisors, and Analysts, to Attend its Real-Time, Interactive Presentation at The Emerging Growth ConferencePETALUMA,…